Information

Sitagliptin Phosphate Monohydrate is a DPP-4 inhibitor API used in the treatment of Type 2 Diabetes Mellitus. It helps regulate blood glucose levels by enhancing the body's natural incretin hormones, thereby improving insulin secretion and reducing glucagon release. It is widely used in oral antidiabetic formulations, either alone or in combination with other diabetes medications.

Log in

See all the content and easy-to-use features by logging in or registering!